Biotech and Pharmaceuticals

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay 0 million
Health

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California.  Justin Sullivan | Getty Images Johnson & Johnson has reached a tentative settlement to resolve an investigation by more than 40 states into claims that the company misled patients about the safety of […]

Read More
Appeals courtroom upholds &#x27pharma bro&#x27 Martin Shkreli life span ban from drug industry
World

Appeals courtroom upholds &#x27pharma bro&#x27 Martin Shkreli life span ban from drug industry

Martin Shkreli, previous main executive officer of Turing Prescribed drugs AG, exits court in New York, US, on Wednesday, Oct. 4, 2023.  Yuki Iwamura | Bloomberg | Getty Pictures A federal appeals courtroom Tuesday upheld a life time ban on “pharma bro” Martin Shkreli from performing in the prescribed drugs business as perfectly as an […]

Read More
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
Health

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical and medical devices businesses surged. J&J also provided full-year […]

Read More
Gilead stock falls after disappointing lung cancer study results
Health

Gilead stock falls after disappointing lung cancer study results

Sopa Images | Lightrocket | Getty Images Shares of Gilead fell more than 9% on Monday after a key drug from the company did not significantly extend the lives of patients with a certain lung cancer in a late-stage trial. The results are a blow to Gilead, which is working to become a power player […]

Read More
Missed the Novo and Lilly rally? These 4 under-the-radar anti-obesity drug stocks could soar, Berenberg says – giving one 44% upside
Health

Missed the Novo and Lilly rally? These 4 under-the-radar anti-obesity drug stocks could soar, Berenberg says – giving one 44% upside

The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers Novo Nordisk and Eli Lilly , according to Berenberg. The Germany-headquartered investment bank expects a combination of new clinical data, and the expiry of Novo ‘s patent for the active ingredient in first-generation GLP-1 drugs, […]

Read More
The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space
Health

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead the market for popular weight loss drugs, which could […]

Read More
US Fda approves Vertex/CRISPR gene remedy for an inherited blood ailment
World

US Fda approves Vertex/CRISPR gene remedy for an inherited blood ailment

The headquarters of US biopharmaceutical firm Vertex Prescribed drugs in Boston, Massachusets, on November 4, 2023. Joseph Prezioso | Afp | Getty Visuals The U.S. overall health regulator has accepted Vertex Prescription drugs and CRISPR Therapeutics’ gene therapy to address a exceptional blood ailment requiring standard blood transfusions, in sufferers 12 several years and older, […]

Read More
&#x27A trove of rebound possibilities&#x27: Strategists change bullish on biotech and much more, choosing leading stocks
World

&#x27A trove of rebound possibilities&#x27: Strategists change bullish on biotech and much more, choosing leading stocks

2023 was not a good year for the overall health-treatment sector, but some traders be expecting it to make a comeback this 12 months — highlighting biotech and medical tech as parts to view. “Rising from a lousy money raising atmosphere in ’22-23, exactly where early-stage biotech firms grappled to fund their Research and Advancement […]

Read More
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
Health

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. […]

Read More
CVS to close ‘select’ pharmacies in Target stores in the coming months
Health

CVS to close ‘select’ pharmacies in Target stores in the coming months

CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle to boost profits.  The closures will begin in February and finish by the end of April, the spokesperson said in a statement. She added that employees affected by the […]

Read More